zeria pharmaceutical co ltd (4559:Tokyo)

Financial Statements for zeria pharmaceutical co ltd (4559)

Currency in Millions of Japanese Yens	As of:	Mar 31 2009 JPY	Mar 31 2010 JPY	Mar 31 2011 JPY	Mar 31 2012 JPY	4 Year Trend
Revenues		47,670.5	50,745.7	49,482.0	53,169.0
TOTAL REVENUES		47,670.5	50,745.7	49,482.0	53,169.0
Cost of Goods Sold		22,257.2	23,300.8	18,410.0	18,523.0
GROSS PROFIT		25,413.3	27,445.0	31,072.0	34,646.0
Selling General & Admin Expenses, Total		18,959.6	20,004.6	22,556.0	24,770.0
R&D Expenses		5,128.1	5,865.7	5,281.0	5,308.0
Other Operating Expenses		1.0	-16.1	--	--
OTHER OPERATING EXPENSES, TOTAL		24,088.7	25,854.3	27,837.0	30,078.0
OPERATING INCOME		1,324.6	1,590.7	3,235.0	4,568.0
Interest Expense		-259.5	-267.5	-290.0	-295.0
Interest and Investment Income		179.3	186.4	233.0	277.0
Other Non-Operating Expenses, Total		2.2	26.0	-184.0	-133.0
Other Non-Operating Income (Expenses)		2.2	26.0	-13.0	-86.0
Gain (Loss) on Sale of Investments		276.3	-243.3	--	32.0
Gain (Loss) on Sale of Assets		--	0.1	104.0	-1.0
Other Unusual Items, Total		481.1	276.2	-336.0	233.0
EBT, INCLUDING UNUSUAL ITEMS		2,004.0	1,568.6	2,762.0	4,681.0
Income Tax Expense		800.8	566.8	928.0	1,765.0
Minority Interest in Earnings		--	--	8.0	-55.0
Earnings from Continuing Operations		1,203.1	1,001.8	1,834.0	2,916.0
NET INCOME		1,203.1	1,001.8	1,842.0	2,861.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS		1,203.1	1,001.8	1,842.0	2,861.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS		1,203.1	1,001.8	1,842.0	2,861.0

Report Data Issue

To contact ZERIA PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.